Reports Volume Coverage on ZOOM, FARE, BAC, and ARIA

Follow this company

Companies Mentioned

12/03/2013 [ACCESSWIRE]

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at to get exclusive access to our free stock reports.

ZOOM Technologies, Inc. (NASDAQ: ZOOM) shares closed down 25.70 percent on Monday with over 1 million shares traded. The stock had one of the biggest drops on the NASDAQ and retraced after seeing gains of over 160 percent this past Friday. The company reported 2013 third quarter results. The company reported a net loss of $14.09 million compared to net income of $0.75 million in same quarter last year.

Get more information on ZOOM Technologies, Inc. and free access to the in-depth equity report at:

World Moto, Inc. (OTCBB: FARE) shares closed up 16.49 percent on Monday making the stock one of the biggest gainers in the OTCBB market. The stock traded a little over 7.8 million shares yesterday and hit a high of 0.12 during intra-day trading. The company announced that the recent debut of its revolutionary Wheelies technology has generated high demand from potential customers. Changing the way the world goes around, World Moto is a global authority on the $500 billion dollar a year motorcycle taxi industry and inventor of the Wheelies and the Moto-Meter, the world's first motorcycle taxi meter.

Get more information on World Moto, Inc. and free access to the in-depth equity report at:

Bank of America Corporation (NYSE: BAC) shares closed down a modest 0.57 percent on Monday on nearly 93 million shares traded. The company announced that it has agreed to pay government-sponsored entity Freddie Mac (NASDAQOTCBB: FMCC) more than $400 million to settle claims related to toxic mortgages created by subprime mortgage mill Countrywide.

Get more information on of Bank of America Corporation and free access to the in-depth equity report at: 

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) shares closed up 1.86 percent yesterday on about 34.6 million shares traded. Levi & Korsinsky announced that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased ARIAD Pharmaceuticals, Inc. ("ARIAD" or the "Company") (NASDAQ: ARIA) stock between December 12, 2011 and October 8, 2013. The Complaint alleges that throughout the Class Period defendants made false and misleading statements regarding the safety and efficacy of the leukemia drug Iclusig.

Get more information on Ariad Pharmaceuticals Inc. and free access to the in-depth equity report at:


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.


Leave a comment...

Your Name